Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 8 (RPL17P8)

Target
RPL17P8
Molecular classification
Other (pseudogene)
01

Overview

RPL17P8 (Ribosomal protein L17 pseudogene 8) is a processed pseudogene in the human genome[1]. Pseudogenes are non-functional segments of DNA that resemble functional genes but do not encode functional proteins. RPL17P8 is derived from the ribosomal protein L17 (RPL17) gene but lacks coding potential, and there is no evidence that it produces a functional protein or acts as a therapeutic target. The RPL17 gene itself encodes a core component of the large 60S ribosomal subunit involved in protein synthesis[3], but RPL17P8 is only a noncoding genomic relic. There are no known disease associations, biomarkers, therapeutic drugs, or mechanisms of action involving this pseudogene.\n\nNote:\n- The designation \"pseudogene\" indicates it is not an active gene product, receptor, enzyme, or druggable target.\n- There is no evidence in current genomic or drug databases indicating that RPL17P8 plays a regulatory or functional role in humans[1][9].\n- If a functional molecule or gene is intended, RPL17 (Ribosomal protein L17, functional gene) could be relevant, but RPL17P8 is not a relevant target for therapeutic or diagnostic purposes[1][3].

Other names
RPL17_4_153RPL17P8[1]
02

Biological functions

None established; not known to have a biological function in humans
03

Disease associations

None established; not associated with disease

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 8 (RPL17P8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 8 (RPL17P8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call